Sofinnova Partners Leads €13M Investment in AI Biology Startup Ingenix
WARSAW, Poland, June 3, 2026 Ingenix, an emerging artificial intelligence company focused on transforming drug discovery through advanced biological...
Capital for New Therapy
Evogene Reports Positive Phase 1 Data for BMC128 in Cancer
REHOVOT, Israel, June 2, 2026 Evogene Ltd. has announced the successful completion of the first-in-human Phase 1 clinical study...
HanchorBio Expands Global Growth Strategy With Taiwan Listing and HCB101 Clinical Progress
TAIPEI, Taiwan, SHANGHAI, China and SAN FRANCISCO, California — May 28, 2026 HanchorBio, Inc. announced that the company will...
Optimi Health Prices $15M Nasdaq Uplisting Offering
VANCOUVER, British Columbia, May 20, 2026 Optimi Health Corp. has announced the pricing of an oversubscribed US$15 million underwritten...
Butterfly Medical Advances Minimally Invasive BPH Technology With $21M
BOSTON and YOKNEAM, Israel, May 14, 2026 Butterfly Medical announced the successful completion of an upsized $21 million Series...
Zymeworks Launches $125M Share Repurchase Program
VANCOUVER, British Columbia, May 14, 2026 Zymeworks Inc. announced that its Board of Directors has approved a new 2026...
Isomorphic Labs Raises $2.1B for AI Drug Discovery
LONDON, May 12, 2026 Isomorphic Labs has secured a massive $2.1 billion Series B funding round to accelerate the...
Moleculent Raises $20M to Scale Functional Profiling Platform
Stockholm, Sweden | April 30, 2026 Moleculent has announced the successful closing of a $20 million financing round, aimed...
Fathom Therapeutics Raises $47M to Advance AI Drug Design
NEW YORK, April 27, 2026 Fathom Therapeutics has announced the successful completion of an oversubscribed $47 million Series A...
Telix and Regeneron Partner to Advance Radiopharma Therapies
Melbourne, Australia & Tarrytown, New York | April 13, 2026 Telix Pharmaceuticals and Regeneron Pharmaceuticals have announced a strategic...